China A-share innovative drug sector extended gains. Wanbang Pharma earlier
sealed the board at the limit-up; Shuanglu Pharmaceutical, Kangyuan
Pharmaceutical and Asymchem hit 10% limit-up. Jiangsu Hengrui Medicine advanced
more than 8%; WuXi AppTec, Changshan Pharmaceutical and other drug names also
rose.